GridAI Technologies (GRDX) Long-Term Debt Issuances (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Long-Term Debt Issuances came in at $700000.0 in Q1 2025, up 209.71% on a YoY basis from $226015.0 in Q1 2024, and up 14.23% quarter-over-quarter from $612784.0 in Q4 2024.
Analysis
GridAI Technologies (GRDX) Long-Term Debt Issuances (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has reported Long-Term Debt Issuances for 11 consecutive years, with $700000.0 the latest figure, recorded in Q1 2025.
- For the quarter ending Q1 2025, Long-Term Debt Issuances rose 209.71% year-over-year to $700000.0; the trailing twelve-month figure through Sep 2025 stood at $1.3 million (up 608.56% YoY), and the FY2025 full-year result was $2.3 million, up 256.82% from the prior year.
- Long-Term Debt Issuances advanced to $700000.0 in Q1 2025 per GRDX's latest filing, from $612784.0 in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $700000.0 in Q1 2025 and bottomed at -$552405.0 in Q4 2021.
- Historically, Long-Term Debt Issuances has averaged $184950.9 across 5 years, with a median of $215308.5 in 2021.
- The sharpest annual moves came in 2024 and 2025: Long-Term Debt Issuances sank 185.59% in 2024, then jumped 209.71% in 2025.
- Over 5 years, Long-Term Debt Issuances stood at -$552405.0 in 2021, then jumped by 129.31% to $161909.0 in 2022, then retreated by 5.21% to $153478.0 in 2023, then surged by 299.27% to $612784.0 in 2024, then gained by 14.23% to $700000.0 in 2025.
- According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $700000.0, $612784.0, and -$194217.0 for Q1 2025, Q4 2024, and Q2 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 1.32 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 700,000.00 |
| Dec 31, 2024 | 612,784.00 |
| Jun 30, 2024 | -194,217.00 |
| Mar 31, 2024 | 226,015.00 |
| Sep 30, 2023 | 153,478.00 |
| Jun 30, 2023 | 226,912.00 |
| Mar 31, 2023 | 223,104.00 |
| Sep 30, 2022 | 161,909.00 |
| Jun 30, 2022 | 240,857.00 |
| Mar 31, 2022 | 238,470.00 |
| Dec 31, 2021 | -552,405.00 |
| Sep 30, 2021 | 139,569.00 |
| Jun 30, 2021 | 207,513.00 |
| Mar 31, 2021 | 205,323.00 |
| Mar 31, 2020 | 3.23 Mn |
| Dec 31, 2019 | 2.97 Mn |
| Mar 31, 2019 | 2.00 Mn |
| Dec 31, 2018 | 127,023.00 |
| Sep 30, 2018 | 26,836.00 |
| Jun 30, 2018 | 53,303.00 |